Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 26, 2019
New data on cancer disparities in Washington
Health equity, patient voices and patient-engaged research hot topics at Value in Cancer Care Summit
Hutch CIO gives keynote at Hopperx1 women-in-tech conference
Kathy Alexion spoke about cloud computing's potential to accelerate cancer research
Dr. Veena Shankaran named 2019 Leader in Health Care
Seattle Business magazine honors oncologist, health services researcher
Dr. Veena Shankaran joins leadership of Fred Hutch’s health care economics and policy research institute
She will contribute to strategic planning, scientific priority setting, fundraising and organizational development
Highlights of Fred Hutch science in 2018
A look back at notable advances in immunotherapy, precision screening and more
7 lung cancer misconceptions
Myths and misinformation still keep many people in the dark – and that’s bad news for their health
HICOR receives 2-year, $250K award to boost patient engagement
Award to health economics group aims to strengthen the role of patients in research
Biologics and biosimilars step onto the cancer therapy stage
Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?
Fred Hutch, Microsoft partner to improve cancer care delivery
Project to flag treatment-related symptoms early is revealed at Seattle conference
Hutch health economics releases first public report on cancer care quality and cost
Community Cancer Care Report on quality and cost is the product of five years of stakeholder collaboration
President's Cancer Panel addresses cost of cancer drugs
Fred Hutch leaders helped shape recommendations that put patients first, promoting value, affordability, innovation
Good News: Fred Hutch joins coalition that seeks to increase transparency on life science career prospects
Celebrating faculty and staff achievements
Big study finds no rise in death risk among women who took hormone therapy
A new twist to menopausal hormone replacement dilemma
New guidelines take aim at chemo-related nausea
Cancer patients ‘should not be vomiting with chemo anymore.’ Can someone please tell Hollywood?
Surviving cancer without going broke
HICOR’s Value in Cancer Care Summit tackles skyrocketing costs, financial toxicity, balancing cost with the right care and more
Good News: Gene therapy for sickle cell disease, and more
Celebrating faculty and staff achievements
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
Collaborating to boost value-based care
HICOR hammers out solutions, addresses hard questions on cost and cancer care at third annual summit
Commentary: Oncologist speaks out on human toll of high health care costs
A Fred Hutch researcher speaks out on the human cost of the ‘unfettered, unbridled greed’ within our health care system
Researching your cancer online: dive in or steer clear?
Some patients feel control over disease by scouring Web; others stoke hope by staying off Internet
Cancer, bankruptcy and death: study finds a link
A new Fred Hutch study finds that the 3 percent of cancer patients who go bankrupt are much more likely to die
Why 1 in 5 cancer clinical trials fizzle
20 percent of studies don’t draw enough participants, new report shows